Researchers say smoking and diabetes likely have link to brain calcifications.
Computed tomography imaging suggests an increased risk of hippocampal calcifications among people who are older, have diabetes mellitus, or who smoke, according to a study published in the journal Radiology.
Researchers from the Netherlands performed a retrospective cross-sectional study to identify risk factors for hippocampal calcifications and to investigate the association between these calcifications and cognitive function. A total of 1,991 patients (mean age 78 years) participated in the study.
All patients underwent cognitive screening in addition to standard diagnostic work-up and brain CT. “A multiplanar CT scan makes it possible to see the hippocampus in different anatomical planes; for example, from top to bottom, right to left and front to back,” lead author, Esther J.M. de Brouwer, MD, a geriatrician at the University Medical Center in Utrecht, said in a release. “Before multiplanar CT scans, hippocampal calcifications were often mistaken for choroid plexus calcifications. So with multiplanar CT scans, hippocampal calcifications are better distinguished from calcifications in other areas.”
The results showed that most 829 of the 1,991 patients (41.6 percent) had Alzheimer’s disease, 490 (23.6 percent) had mild cognitive impairment, and 332 (16.7 percent) had subjective cognitive impairment. A total of 380 of the 1,991 patients had hippocampal calcifications. Older age, diabetes mellitus, and smoking were associated with their presence, although no association was found between the presence and the severity of hippocampal calcifications and cognitive function.
“We do think that smoking and diabetes are risk factors,” de Brouwer said in the release. “In a recent histopathology study, hippocampal calcifications were found to be a manifestation of vascular disease. It is well known that smoking and diabetes are risk factors for cardiovascular disease. It is, therefore, likely that smoking and diabetes are risk factors for hippocampal calcifications.”
The researchers plan more studies to further examine the possible links.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.